LAURUS LABS Financial Statement Analysis
|
||
The Revenues of LAURUS LABS have increased by 10.18% YoY .
The Earnings Per Share (EPS) of LAURUS LABS has increased by 126.62 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
LAURUS LABS Last 5 Annual Financial Results
[BOM: 540222|NSE : LAURUSLABS]
Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|---|
Revenues | ₹5,554 Cr | ₹5,041 Cr | ₹6,041 Cr | ₹4,936 Cr | ₹4,814 Cr |
Expenses | ₹4,499 Cr | ₹4,263 Cr | ₹4,448 Cr | ₹3,513 Cr | ₹3,263 Cr |
Operating Profit (Excl OI) | ₹1,055 Cr | ₹778 Cr | ₹1,592 Cr | ₹1,422 Cr | ₹1,551 Cr |
Other Income | ₹75 Cr | ₹26 Cr | ₹6.00 Cr | ₹15 Cr | ₹24 Cr |
Interest | ₹216 Cr | ₹183 Cr | ₹165 Cr | ₹102 Cr | ₹68 Cr |
Depreciation | ₹430 Cr | ₹385 Cr | ₹324 Cr | ₹251 Cr | ₹205 Cr |
Profit Before Tax | ₹484 Cr | ₹236 Cr | ₹1,109 Cr | ₹1,084 Cr | ₹1,301 Cr |
Profit After Tax | ₹354 Cr | ₹168 Cr | ₹797 Cr | ₹832 Cr | ₹984 Cr |
Consolidated Net Profit | ₹358 Cr | ₹158 Cr | ₹785 Cr | ₹828 Cr | ₹984 Cr |
Earnings Per Share (Rs) | ₹6.64 | ₹2.93 | ₹14.56 | ₹15.40 | ₹18.33 |
PAT Margin (%) | 6.38 | 3.34 | 13.19 | 16.87 | 20.44 |
ROE(%) | 8.30 | 4.15 | 21.63 | 28.05 | 45.15 |
ROCE(%) | 10.16 | 6.64 | 22.97 | 25.97 | 39.82 |
Total Debt/Equity(x) | 0.61 | 0.61 | 0.49 | 0.52 | 0.56 |
Key Financials |
||
Market Cap | : | ₹ 40,254.2 Cr |
Revenue (TTM) | : | ₹ 5,554.0 Cr |
Net Profit(TTM) | : | ₹ 354.4 Cr |
EPS (TTM) | : | ₹ 6.6 |
P/E (TTM) | : | 113.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
LAURUS LABS | 11.4% | 22% | 71.1% |
SUN PHARMACEUTICAL INDUSTRIES | -0.2% | -0.5% | 10.7% |
DIVIS LABORATORIES | 4% | 4.8% | 50.5% |
CIPLA | 0.4% | 3.1% | 1.6% |
TORRENT PHARMACEUTICALS | 5.9% | 9.1% | 23% |
DR REDDYS LABORATORIES | -4.8% | 2.2% | 2.9% |
MANKIND PHARMA | -0.9% | -5.2% | 8.7% |
ZYDUS LIFESCIENCES | 2.7% | 7.8% | -6.5% |
LUPIN | 1.4% | 0.1% | 22.3% |
LAURUS LABS Revenues
[BOM: 540222|NSE : LAURUSLABS]
Y-o-Y | 10.18 % |
5 Yr CAGR | 3.64 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹5,554 Cr | 10.18 | |
Mar2024 | ₹5,041 Cr | -16.55 | |
Mar2023 | ₹6,041 Cr | 22.39 | |
Mar2022 | ₹4,936 Cr | 2.54 | |
Mar2021 | ₹4,814 Cr | - |
LAURUS LABS Operating Profit
[BOM: 540222|NSE : LAURUSLABS]
Y-o-Y | 35.73 % |
5 Yr CAGR | -9.17 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹1,055 Cr | 35.73 | |
Mar2024 | ₹778 Cr | -51.17 | |
Mar2023 | ₹1,592 Cr | 11.93 | |
Mar2022 | ₹1,422 Cr | -8.27 | |
Mar2021 | ₹1,551 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 23.22 % |
5 Yr CAGR | -12.37 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 19% | 23.22 | |
Mar2024 | 15.42% | -41.50 | |
Mar2023 | 26.36% | -8.54 | |
Mar2022 | 28.82% | -10.55 | |
Mar2021 | 32.22% | - |
LAURUS LABS Profit After Tax
[BOM: 540222|NSE : LAURUSLABS]
Y-o-Y | 127.25 % |
5 Yr CAGR | -22.31 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹358 Cr | 127.25 | |
Mar2024 | ₹158 Cr | -79.90 | |
Mar2023 | ₹785 Cr | -5.20 | |
Mar2022 | ₹828 Cr | -15.87 | |
Mar2021 | ₹984 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 91.02 % |
5 Yr CAGR | -25.25 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 6.38 % | 91.02 | |
Mar2024 | 3.34 % | -74.68 | |
Mar2023 | 13.19 % | -21.81 | |
Mar2022 | 16.87 % | -17.47 | |
Mar2021 | 20.44 % | - |
LAURUS LABS Earnings Per Share (EPS)
[BOM: 540222|NSE : LAURUSLABS]
Y-o-Y | 126.62 % |
5 Yr CAGR | -22.42 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹6.64 | 126.62 | |
Mar2024 | ₹2.93 | -79.88 | |
Mar2023 | ₹15 | -5.45 | |
Mar2022 | ₹15 | -15.98 | |
Mar2021 | ₹18 | - |
LAURUS LABS Return on Capital Employed (ROCE)
[BOM: 540222|NSE : LAURUSLABS]
Y-o-Y | 53.01 % |
5 Yr CAGR | -28.93 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 10.16% | 53.01 | |
Mar2024 | 6.64% | -71.09 | |
Mar2023 | 22.97% | -11.55 | |
Mar2022 | 25.97% | -34.78 | |
Mar2021 | 39.82% | - |
LAURUS LABS Share Price vs Sensex
Current Share Price | : | ₹746.0 |
Current MarketCap | : | ₹ 40,254.2 Cr |
Updated EOD on | : | Jul 01,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | 11.4% |
22% |
71.1% |
SENSEX | 2% |
2.8% |
6.4% |
LAURUS LABS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE LARGEMIDCAP | 4.5% | 7.2% | 8.3% |
BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
BSE 250 SMALLCAP INDEX | 3.1% | 5.1% | 2.4% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MIDSMALL HEALTHCARE | 3.5% | 5.1% | 23.1% |
NIFTY SMALLCAP 250 | 3.4% | 5.5% | 3.9% |
NIFTY SMALLCAP 100 | 3.3% | 6.6% | 4.2% |
NIFTY SMALLCAP 50 | 3.1% | 7.3% | 7.3% |
NIFTY 500 EQUAL WEIGHT | 2.7% | 3.7% | 3.4% |
You may also like the below Video Courses
FAQ about LAURUS LABS Financials
How the annual revenues of LAURUS LABS have changed ?
The Revenues of LAURUS LABS have increased by 10.18% YoY .
How the Earnings per Share (EPS) of LAURUS LABS have changed?
The Earnings Per Share (EPS) of LAURUS LABS has increased by 126.62 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs